Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
532296
Company
GLENMARK PHARMACEUTICALS LTD.
Exchange Received Time
12/05/2020 09:33:10
Exchange Disseminated Time
12/05/2020 09:33:19
Time Taken
00:00:09
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
05/12/20 09:33
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
Attachment
<< Back
Recently Viewed